Kintara Therapeutics Probability of Future Stock Price Finishing Over 30.55

KTRADelisted Stock  USD 6.30  0.14  2.17%   
Kintara Therapeutics' future price is the expected price of Kintara Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kintara Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
  
Please specify Kintara Therapeutics' target price for which you would like Kintara Therapeutics odds to be computed.

Kintara Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kintara Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kintara Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kintara Therapeutics is now traded under the symbol HURA. Please update your portfolios or report it if you believe this is an error. Report It!
Kintara Therapeutics is not yet fully synchronised with the market data
Kintara Therapeutics had very high historical volatility over the last 90 days
Kintara Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (8.32 M) with profit before overhead, payroll, taxes, and interest of 0.
Kintara Therapeutics currently holds about 11.78 M in cash with (7.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.

Kintara Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kintara Stock often depends not only on the future outlook of the current and potential Kintara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kintara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.6 M
Cash And Short Term Investments4.9 M

Kintara Therapeutics Technical Analysis

Kintara Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Kintara Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kintara Therapeutics. In general, you should focus on analyzing Kintara Stock price patterns and their correlations with different microeconomic environments and drivers.

Kintara Therapeutics Predictive Forecast Models

Kintara Therapeutics' time-series forecasting models is one of many Kintara Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kintara Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Kintara Therapeutics

Checking the ongoing alerts about Kintara Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kintara Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kintara Therapeutics is now traded under the symbol HURA. Please update your portfolios or report it if you believe this is an error. Report It!
Kintara Therapeutics is not yet fully synchronised with the market data
Kintara Therapeutics had very high historical volatility over the last 90 days
Kintara Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (8.32 M) with profit before overhead, payroll, taxes, and interest of 0.
Kintara Therapeutics currently holds about 11.78 M in cash with (7.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Kintara Stock

If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets